,,ii  #aafth ,,congress  #ast ,session  
,s4 #igg  ,,in ,,the ,,senate ,,of ,,the
 ,,united ,,states  ,april #a1 #bjai,mr4
 ,scott of ,florida 7for himself and    
,mr4 ,hawley7 introduced the following  
bill2 which was read twice and referred 
to the ,committee on ,health1           
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to address the high cost of    
prescription drugs4  #a4 ,short title   
,this ,act may be cited as the          
,transparent ,drug ,pricing ,act of     
#bjai4  #b4 ,price transparency at      
pharmacies ,section #aibg7;g77#b7 of the
 ,social ,security ,act 7#db ,u4,s4,c4  
#acifr-#h7;g77#b77 is amended by adding 
at the end the following new            
subparagraph3  7,e7 ,disclosure of drug 
prices at point of sale ,beginning      
,january #a1 #bjbb1 as part of a        
,state's drug use review program1       
applicable ,state law shall require     
pharmacists to disclose to customers1 at
 the point of sale of any prescription  
drug-- 7i7 the customer's out-of-pocket 

cost with respect to acquisition of such
 drug under the health plan in which the
 customer is enrolled1 if applicable2   
and  7ii7 the cost to the consumer for  
acquisition of the drug without using   
any health plan4  4  #c4 ,requirements  
with respect to prescription drug       
cost-sharing ,subpart ,,ii of part ,a of
 title ,,xxvii of the ,public ,health   
,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aa
 et seq47 is amended by adding at the   
end the following3  #bgbi;,a4           
,requirements with respect to           
prescription drug cost-sharing  7a7     
,credit towards deductible ,with respect
 to any enrollee in a health plan or    
individual or group health insurance    
coverage who pays out-of-pocket for the 
full cost of a prescription drug1 the   
group health plan or health insurance   
issuer offering such health insurance   
coverage shall credit the full amount   
such enrollee paid for such drug towards
 any deductible under the plan or       
coverage applicable to prescription     

drugs4  7b7 ,establishment of           
co-,payments for certain prescription   
drugs  7#a7 ,in general ,a group health 
plan or a health insurance issuer       
offering group or individual health     
insurance coverage shall1 not later than
 #fj days before the first annual open  
enrollment period after the date of     
enactment of the ,transparent ,drug     
,pricing ,act of #bjai1 and #fj days    
before each annual open enrollment      
period thereafter1 publish a list of the
 co-payment amounts for the applicable  
plan year with respect to each          
prescription drug covered under the plan
 or coverage4  7#b7 ,prohibition on     
changes in co-payment amounts ,a group  
health plan or health insurance issuer  
described in paragraph 7#a7 may not     
change the co-payment amount published  
in accordance with paragraph 7#a7 until 
the next plan year4  7#c7 ,calculation  
of out-of-pocket costs ,a group health  
plan or a health insurance issuer       
offering group or individual health     

insurance coverage shall provide a      
mechanism that enables enrollees in the 
plan or coverage to determine the       
projected total out-of-pocket costs of  
an enrollee in the plan or coverage for 
each prescription drug covered under    
such plan or coverage4  4  #d4          
,international retail list price index  
7a7 ,in general ,the retail list price  
in the ,united ,states for a drug       
approved under subsection 7c7 or 7j7 of 
section #eje of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cee7 or a biological product licensed 
under subsection 7a7 or 7k7 of section  
#cea of the ,public ,health ,service    
,act 7#db ,u4,s4,c4 #bfb7 may not exceed
 the lowest retail list price for the   
drug among ,canada1 ,france1 the ,united
 ,kingdom1 ,japan1 or ,germany4  7b7    
,sunset ,the requirement under          
subsection 7a7 shall terminate on the   
date that is #e years after the date of 
enactment of this ,act4